Results 241 to 250 of about 721,252 (305)

A synchronous presentation of thyroid follicular carcinoma-like renal tumor and papillary vesicular thyroid tumors: About an exceptional case and review of the literature. [PDF]

Int J Surg Case Rep
Ziani I, Azzam I, Ouaziz H, Ibrahimi A, Nouini Y.   +4 more
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 14 No. 3 [PDF]

, 1978

core   +1 more source

OCIAD2 Stabilizes Integrin β1 Signaling Through SNX17‐Mediated Endosomal Recycling to Lipid Rafts and Modulates Cisplatin Response in HNSCC

Advanced Science, EarlyView.
This study identifies OCIAD2 as a critical regulator of cisplatin resistance in HNSCC. Mechanistically, OCIAD2 stabilizes integrin β1 through a direct physical interaction and facilitates its SNX17‐dependent endosomal recycling to lipid raft microdomains. Targeting OCIAD2 disrupts integrin β1 trafficking and significantly enhances cisplatin sensitivity,
Li Cui, Shanshan Si, Min Ye, Pei Lin, Meiyan Zou, Yunfan Lin, Xu Chen, Bing Guo, Wenjuan Sun, Xinyuan Zhao   +9 more
wiley   +1 more source

Scrutinizing VTE risk factors in complex renal tumor patients: a comprehensive look at the VTE-RT-IVCTT study. [PDF]

Int J Surg
Chen R, Mei Z, Chen J.
europepmc   +1 more source

DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway

Advanced Science, EarlyView.
Lenvatinib resistance poses a major challenge in advanced hepatocellular carcinoma (HCC). This study reveals that DNMT2 upregulation is a key driver, which stabilizes ACLY mRNA via m5C modification and activates the Notch signaling pathway. Crucially, combining ACLY inhibitors with lenvatinib overcomes resistance and suppresses tumors, offering a ...
Shiguang Yang, Jie Li, Shengwei Mao, Xuhui Zhao, Douwaner Liu, Jiafeng Chen, Jialu Fu, Yichao Bu, Xiaoling Wu, Shaoqing Liu, Qifeng Yu, Qiongzhu Dong, Zheng Tang, Yuan Fang, Yinghong Shi   +14 more
wiley   +1 more source

Polarization-sensitive optical coherence tomography for renal tumor detection in ex vivo human kidneys. [PDF]

Opt Lasers Eng
Yan F, Wang C, Yan Y, Zhang Q, Yu Z, Patel SG, Fung KM, Tang Q.   +7 more
europepmc   +1 more source

A commentary on 'Risk factors for incident venous thromboembolism in patients with renal tumor and inferior vena cava tumor thrombus: A retrospective case-control study'. [PDF]

Int J Surg
Feng J, Cao Y, Wei J.
europepmc   +1 more source

Preparing for the Worst: Management and Predictive Factors of Open Conversion During Minimally Invasive Renal Tumor Surgery (UroCCR-135 Study). [PDF]

Eur Urol Open Sci
Branger N, Doumerc N, Waeckel T, Bigot P, Surlemont L, Knipper S, Pignot G, Audenet F, Bruyère F, Fontenil A, Parier B, Champy C, Rouprêt M, Patard JJ, Henon F, Fiard G, Guillotreau J, Beauval JB, Michel C, Bernardeau S, Taha F, Mallet R, Panthier F, Guy L, Vignot L, Khene ZE, Bernhard JC.   +26 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Renal tumors ablation

Minerva Urology and Nephrology, 2021
Renal tumors ...
MARCHIONI, Michele, AMPARORE, Daniele, INGELS, Alexandre, CARBONARA, Umberto, PECORARO, Angela, ROUSSEL, Eduard, CAMPI, Riccardo, on behalf of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group   +7 more
openaire   +5 more sources

Renal tumors

Current Opinion in Nephrology and Hypertension, 1993
Renal tumors including renal cortical adenoma, renal cell carcinoma (hypernephroma), oncocytoma, angiomyolipoma (hamartoma), medullary fibroma, juxtaglomerular cell tumor, nephroblastoma (Wilms' tumor), mesoblastic nephroma, renal blastema, sarcoma, and secondary metastatic lesions are discussed.
H C, Ruckle, V E, Torres, R L, Richardson, H, Zincke   +3 more
openaire   +2 more sources